The estimated Net Worth of Ingen Chris Van is at least $3.39 Millón dollars as of 14 June 2017. Ingen Van owns over 19,900 units of Agilent Technologies stock worth over $3,394,960 and over the last 22 years Ingen sold A stock worth over $0.
Sign up
Ingen Van A stock SEC Form 4 insiders trading
Ingen has made over 5 trades of the Agilent Technologies stock since 2005, according to the Form 4 filled with the SEC. Most recently Ingen exercised 19,900 units of A stock worth $396,010 on 14 June 2017.
The largest trade Ingen's ever made was exercising 73,486 units of Agilent Technologies stock on 18 June 2007 worth over $2,156,079. On average, Ingen trades about 5,104 units every 187 days since 2003. As of 14 June 2017 Ingen still owns at least 24,477 units of Agilent Technologies stock.
You can see the complete history of Ingen Van stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
What's Ingen Van's mailing address?
Ingen's mailing address filed with the SEC is 395 PAGE MILL ROAD, MS A3-18, , PALO ALTO, CA, 94306.
Insiders trading at Agilent Technologies
Over the last 22 years, insiders at Agilent Technologies have traded over $170,735,833 worth of Agilent Technologies stock and bought 25,786 units worth $823,096 . The most active insiders traders include William P Sullivan, George A Scangos y Mikael Dolsten. On average, Agilent Technologies executives and independent directors trade stock every 20 days with the average trade being worth of $3,748,368. The most recent stock trade was executed by Padraig Mcdonnell on 22 August 2024, trading 1,958 units of A stock currently worth $283,910.
What does Agilent Technologies do?
analytical scientists and clinical researchers worldwide rely on agilent to help fulfill their most complex laboratory demands. our instruments, software, services and consumables address the full range of scientific and laboratory management needs—so our customers can do what they do best: improve the world around us. whether a laboratory is engaged in environmental testing, academic research, medical diagnostics, pharmaceuticals, petrochemicals or food testing, agilent provides laboratory solutions to meet their full spectrum of needs. we work closely with customers to help address global trends that impact human health and the environment, and to anticipate future scientific needs. our solutions improve the efficiency of the entire laboratory, from sample prep to data interpretation and management. customers trust agilent for solutions that enable insights...for a better world.
What does Agilent Technologies's logo look like?
Complete history of Ingen Van stock trades at Bruker Corp y Agilent Technologies
Agilent Technologies executives and stock owners
Agilent Technologies executives and other stock owners filed with the SEC include:
-
Michael McMullen,
President, Chief Executive Officer, Director -
Robert McMahon,
Chief Financial Officer, Senior Vice President -
Jacob Thaysen,
Senior Vice President, President - Life Sciences and Applied Markets Group -
Michael R. McMullen,
CEO, Pres & Director -
Michael Tang,
Senior Vice President, General Counsel, Secretary -
Robert W. McMahon,
Sr. VP & CFO -
Jacob Thaysen,
Sr. VP and Pres of Life Sciences & Applied Markets Group -
Michael Tang,
Sr. VP, Gen. Counsel & Sec. -
Samraat S. Raha,
Sr. VP and Pres of Diagnostics & Genomics Group -
Boon Hwee Koh,
Non-Executive Independent Chairman of the Board -
Paul Clark,
Independent Director -
Tadataka Yamada,
Independent Director -
Dow Wilson,
Independent Director -
Sue Rataj,
Independent Director -
Daniel Podolsky,
Independent Director -
George Scangos,
Independent Director -
Heidi Kunz,
Independent Director -
Hans Bishop,
Independent Director -
Mala Anand,
Independent Director -
Dominique Grau,
Senior Vice President - Human Resources -
Rodney Gonsalves,
Chief Accounting Officer, Vice President, Corporate Controllership -
Samraat Raha,
Senior Vice President, President - Diagnostics and Genomics Group -
Padraig McDonnell,
Senior Vice President, President - Agilent CrossLab Group -
Henrik Ancher-Jensen,
Senior Vice President, President - Order Fulfillment -
Richard A. Burdsall,
Sr. VP of Global Infrastructure Services -
Rodney Gonsalves,
Principal Accounting Officer, VP & Corp. Controller -
Allison Ballmer,
Sr. VP of Strategy & Corp. Devel. -
Dominique P. Grau,
Sr. VP of HR & Global Communications -
Ankur Dhingra,
VP of Investor Relations -
Dr. Darlene J. S. Solomon,
CTO & Sr. VP -
Robert J Herbold,
Director -
Mark Doak,
Sr. Vice President -
James Cullen,
Director -
Heidi Fields,
Director -
Patrick Kaltenbach,
Sr Vice President -
Mikael Dolsten,
Director -
Adrian T Dillon,
Executive Vice President & CFO -
Didier Hirsch,
Vice President & Controller -
Lonnie G. Justice,
Vice President -
Saleem N. Odeh,
Vice President -
David S Churchill,
Vice President -
Robert L Joss,
Director -
Soon Chai Gooi,
Vice President -
D Craig Nordlund,
Sr VP, General Counsel & Sec. -
Thomas White,
Senior Vice President -
Walter B Hewlett,
Director -
Edward W Barnholt,
President, CEO, and Chairman -
Ingen Chris Van,
Senior Vice President -
Young Sohn,
Senior Vice President -
Dick M Chang,
Senior Vice President -
Jack P Trautman,
Senior Vice President -
David B Jr Cooper,
Senior Vice President -
Patrick J Byrne,
Senior Vice President -
Marie Oh Huber,
Sr VP, General Counsel & Sec. -
William P Sullivan,
EVP & Chief Operating Officer -
A Barry Rand,
Director -
Solange Glaize,
VP, Chief Accounting Officer -
Fred Strohmeier,
Senior Vice President -
David M Lawrence,
Director -
Guy Sene,
Senior Vice President -
Lars Holmkvist,
Senior Vice President -
Ronald S. Nersesian,
Vice President -
Jean Mcclung Nye,
Senior Vice President -
Nicolas H Phd Roelofs,
Vice President -
Simon May,
Senior Vice President -
Otis W Brawley,
Director -
Philip Binns,
Senior Vice President -
Angelica Riemann,
Senior Vice President -
Bret Di Marco,
Senior Vice President